Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Sa | Stock Market Crash Warning: Don't Get Caught Holding These 3 Nasdaq Stocks | 2 | InvestorPlace | ||
Sa | Forget the Nasdaq -- Invest in This Unstoppable ETF Instead | 1 | The Motley Fool | ||
Sa | Stock Market Crash Alert: 7 Must-Buy Nasdaq Stocks When Prices Plunge | 2 | InvestorPlace | ||
Sa | 4 Colossal Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market | 3 | The Motley Fool | ||
Fr | Newbury Street Acquisition Corporation Announces Receipt of Nasdaq Letter | 89 | GlobeNewswire (Europe) | Boston, MA, May 03, 2024 (GLOBE NEWSWIRE) -- Newbury Street Acquisition Corporation (NASDAQ: NBST, the "Company") announced today that it received a letter dated April 24, 2024, from the Listing Qualifications... ► Artikel lesen | |
Fr | Ferrovial Completes Regulatory Review Process for Nasdaq Listing | 79 | PR Newswire | Listing marks intent to expand already-robust presence in North America
AMSTERDAM, May 3, 2024 /PRNewswire/ -- Ferrovial SE ("Ferrovial" or the "Company"), one of the world's leading infrastructure... ► Artikel lesen | |
Fr | Delcath Systems, Inc.: Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 66 | PR Newswire | NEW YORK, May 3, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers... ► Artikel lesen | |
Fr | Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 37 | GlobeNewswire (Europe) | BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies... ► Artikel lesen | |
Fr | Jayud Global Logistics receives non-compliance notice from Nasdaq | 1 | Seeking Alpha | ||
Fr | Quantum provides updated plan to Nasdaq | 1 | Seeking Alpha | ||
Fr | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 41 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO and SAN DIEGO, May 03, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms... ► Artikel lesen | |
Fr | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 40 | GlobeNewswire (Europe) | MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve... ► Artikel lesen | |
Fr | Jayud Global Logistics Ltd: Jayud Global Logistics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5550(b) | 85 | GlobeNewswire (Europe) | SHENZHEN, China, May 03, 2024 (GLOBE NEWSWIRE) -- Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company"), a leading end-to-end supply chain solution provider based in Shenzhen, specializing... ► Artikel lesen | |
Fr | Dianthus Therapeutics, Inc.: Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 45 | GlobeNewswire (Europe) | NEW YORK and WALTHAM, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. ("Dianthus"), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody... ► Artikel lesen | |
Fr | Mersana Therapeutics, Inc.: Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 38 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug... ► Artikel lesen | |
Fr | NASDAQ, INC. - 8-K, Current Report | 2 | SEC Filings | ||
Fr | Mural Oncology, Inc.: Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 32 | GlobeNewswire (Europe) | WALTHAM, Mass and DUBLIN, May 03, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company leveraging its core competencies in immune cell modulation and... ► Artikel lesen | |
Fr | Arcutis Biotherapeutics, Inc.: Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 128 | GlobeNewswire (Europe) | WESTLAKE VILLAGE, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in... ► Artikel lesen | |
Fr | Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 45 | GlobeNewswire (Europe) | BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing... ► Artikel lesen | |
Fr | Vor Biopharma: Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 49 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of May 1, 2024, the Compensation... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 2.842 |
NEL | 1.645 |
APPLE | 1.526 |
BAYER | 1.491 |
BYD | 1.485 |
SUPER MICRO COMPUTER | 1.359 |
DEUTSCHE BANK | 1.243 |
TUI | 1.222 |
NVIDIA | 1.221 |
PLUG POWER | 1.081 |
TESLA | 1.036 |
DAIMLER TRUCK | 935 |
MERCEDES-BENZ | 915 |
RHEINMETALL | 898 |
RWE | 893 |
AURUBIS | 807 |
RENK GROUP | 786 |
DEUTSCHE LUFTHANSA | 783 |
VOLKSWAGEN | 763 |
COMMERZBANK | 761 |
AMAZON | 755 |
SIEMENS ENERGY | 693 |
AIXTRON SE | 671 |
SIXT SE VZ | 653 |
ALLIANZ | 620 |